These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 30504819)
1. Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease. Onal EM; Afsar B; Covic A; Vaziri ND; Kanbay M Hypertens Res; 2019 Feb; 42(2):123-140. PubMed ID: 30504819 [TBL] [Abstract][Full Text] [Related]
2. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease. Li DY; Tang WHW Semin Nephrol; 2018 Mar; 38(2):193-205. PubMed ID: 29602401 [TBL] [Abstract][Full Text] [Related]
3. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus. Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993 [TBL] [Abstract][Full Text] [Related]
4. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis. Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR Pflugers Arch; 2020 Mar; 472(3):303-320. PubMed ID: 32064574 [TBL] [Abstract][Full Text] [Related]
6. Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease. Meijers B; Jouret F; Evenepoel P Pharmacol Res; 2018 Jul; 133():101-107. PubMed ID: 29715498 [TBL] [Abstract][Full Text] [Related]
7. [Micro-inflammation and digestive bacterial translocation in chronic kidney disease]. Olivier V; Dunyach-Remy C; Lavigne JP; Moranne O Nephrol Ther; 2018 May; 14(3):135-141. PubMed ID: 29295767 [TBL] [Abstract][Full Text] [Related]
8. The impact of gut microbiota on kidney function and pathogenesis. Mahmoodpoor F; Rahbar Saadat Y; Barzegari A; Ardalan M; Zununi Vahed S Biomed Pharmacother; 2017 Sep; 93():412-419. PubMed ID: 28654798 [TBL] [Abstract][Full Text] [Related]
9. Gut microbiome in chronic kidney disease: challenges and opportunities. Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743 [TBL] [Abstract][Full Text] [Related]
10. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease. Mafra D; Lobo JC; Barros AF; Koppe L; Vaziri ND; Fouque D Future Microbiol; 2014; 9(3):399-410. PubMed ID: 24762311 [TBL] [Abstract][Full Text] [Related]
11. Impact of gut microbiota: How it could play roles beyond the digestive system on development of cardiovascular and renal diseases. Suganya K; Son T; Kim KW; Koo BS Microb Pathog; 2021 Mar; 152():104583. PubMed ID: 33164814 [TBL] [Abstract][Full Text] [Related]
12. Gut microbiota; an overlooked effect of phosphate binders. Rahbar Saadat Y; Niknafs B; Hosseiniyan Khatibi SM; Ardalan M; Majdi H; Bahmanpoor Z; Abediazar S; Zununi Vahed S Eur J Pharmacol; 2020 Feb; 868():172892. PubMed ID: 31870830 [TBL] [Abstract][Full Text] [Related]
13. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine]. Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678 [TBL] [Abstract][Full Text] [Related]
14. Microbiome and Cardiovascular Disease in CKD. Jovanovich A; Isakova T; Stubbs J Clin J Am Soc Nephrol; 2018 Oct; 13(10):1598-1604. PubMed ID: 29743160 [TBL] [Abstract][Full Text] [Related]
15. Alterations of intestinal barrier and microbiota in chronic kidney disease. Sabatino A; Regolisti G; Brusasco I; Cabassi A; Morabito S; Fiaccadori E Nephrol Dial Transplant; 2015 Jun; 30(6):924-33. PubMed ID: 25190600 [TBL] [Abstract][Full Text] [Related]
16. The clinical impact of gut microbiota in chronic kidney disease. Kim SM; Song IH Korean J Intern Med; 2020 Nov; 35(6):1305-1316. PubMed ID: 32872729 [TBL] [Abstract][Full Text] [Related]
17. Intestinal microbiota and diabetic kidney diseases: the Role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression. Mosterd CM; Kanbay M; van den Born BJH; van Raalte DH; Rampanelli E Best Pract Res Clin Endocrinol Metab; 2021 May; 35(3):101484. PubMed ID: 33546983 [TBL] [Abstract][Full Text] [Related]
19. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease. Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359 [TBL] [Abstract][Full Text] [Related]
20. [Gut microbiota and kidney diseases : dangerous liaisons?]. Ghajarzadeh-Wurzner A; Berney M; Teta D; Genton L; Pruijm M Rev Med Suisse; 2018 Feb; 14(595):422-425. PubMed ID: 29465874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]